logo-loader
viewFrontier IP Group PLC

Frontier IP 'in strong position' and working closely with portfolio companies to mitigate new risks

Frontier IP Group PLC's (LON:FIPP) Neil Crabb speaks to Proactive London's Andrew Scott to discuss how the Intellectual property specialist's portfolio companies are adapting to the new virus threat.

Crabb also touches on new investee company Elute Intelligence, in which it holds a 43% stake, which has launched a free online document reader to support scientists researching the current health crisis.

Quick facts: Frontier IP Group PLC

Price: 61 GBX

AIM:FIPP
Market: AIM
Market Cap: £30.92 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Frontier IP Group PLC named herein, including the promotion by the Company of Frontier IP Group PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Frontier IP's The Vaccine Group to begin animal coronavirus vaccine trials...

Frontier IP Group PLC's (LON:FIPP) Neil Crabb tells Proactive London's  Andrew Scott its portfolio company The Vaccine Group is to 'imminently' start trials of its coronavirus vaccine in animals. Crabb says the idea is to develop an animal inoculation that would prevent the spread of...

on 16/3/20

2 min read